Special Drug Use-results survey for long term administration of Reminyl 4mg/8mg/12mg Tablets, 4mg/8mg/12mg OD Tablets, 4mg/mL Oral Solutio
Not Applicable
- Conditions
- Mild to moderately severe dementia of the Alzheimer's type
- Registration Number
- JPRN-UMIN000017151
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
Not provided
Exclusion Criteria
NA
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety (Adverse Drug Reactions) Efficacy (Mini-Mental State Examination, Clinical Global Impression-Improvement scale, Medication Satisfaction Questionnaire of caretaker)
- Secondary Outcome Measures
Name Time Method